Dalia Salem

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Jennifer N. Brudno, Irina Marić, Steven D. Hartman et al. · Journal of Clinical Oncology · 2018 · 791 citations · Full text

Medicine, Hematology, Immunology +15

CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial

Nirali N. Shah, Steven L. Highfill, Haneen Shalabi et al. · Journal of Clinical Oncology · 2020 · 416 citations · Full text

Life Sciences, Hematology, Immunology +17

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Clare Sun, Xin Tian, Yuh Shan Lee et al. · Blood · 2015 · 221 citations · Full text

Life Sciences, Hematology, Immunology +14

Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy

Martin Skarzynski, Carsten Utoft Niemann, Yuh Shan Lee et al. · Clinical Cancer Research · 2015 · 80 citations · Full text

Pharmacy, Immunology, Pharmacology +16

<i>Giardia</i> diagnostic methods in human fecal samples: A comparative study

Hala A El-Nahas, Dalia Salem, Abeer A. Elhenawy et al. · Cytometry Part B Clinical Cytometry · 2012 · 52 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17